Primary-source library

Official drug, device, and pharmacy sources

FDA notices and labels are central research sources, but a report, recall, or safety communication does not prove individual causation. Save dated copies because labels and regulatory information can change.

Links go to the issuing agency, legislature, court material, or public medical source whenever one is available. Each page still explains what the source can and cannot establish in an individual claim.

Published August 23, 2026 · Last reviewed August 23, 2026

U.S. Food and Drug Administration
MedWatch safety reporting
FDA program for reporting serious problems with medical products and reviewing safety information.
Covers: adverse events · safety reports
U.S. Food and Drug Administration
Drugs@FDA
Official database of approved drug products, labels, approval history, and regulatory documents.
Covers: drug labels · approvals · manufacturer
U.S. Food and Drug Administration
Medication errors related to drug products
FDA explanation of medication-error monitoring involving names, labels, packaging, and product design.
Covers: medication errors · labeling
U.S. Food and Drug Administration
Recalls, market withdrawals, and safety alerts
Current and archived notices for FDA-regulated products.
Covers: recalls · safety alerts
Legal Information Institute, Cornell Law School
28 U.S.C. section 1407
Federal statute governing transfer of related civil actions for coordinated multidistrict pretrial proceedings.
Covers: MDL · federal procedure

How sources are selected

We prefer statutes, regulations, issuing agencies, court material, and federal medical or safety sources. A commercial source is used only when it is the primary source for its own policy or product and is labeled accordingly.

Sources support factual background. They do not substitute for jurisdictional research, expert analysis, medical diagnosis, or review of the complete record. Broken links and materially changed guidance are corrected during page review.